chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Injection site pain, Peripheral swelling, Vaccination site bruising
Clinical narrative: COVID arm; Arm was swollen, could not touch shoulder; Red arm, redness down elbow to shoulder; Arm was hard; Injection really hurt; Developed 4 inch bruise; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard) and INJECTION SITE PAIN (Injection really hurt) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard), INJECTION SITE PAIN (Injection really hurt) and VACCINATION SITE BRUISING (Developed 4 inch bruise). At the time of the report, VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard), INJECTION SITE PAIN (Injection really hurt) and VACCINATION SITE BRUISING (Developed 4 inch bruise) outcome was unknown. Not provided          No relevant concomitant product use was reported.  Treatment details included clindamycin.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: COVID arm; Arm was swollen, could not touch shoulder; Red arm, redness down elbow to shoulder; Arm was hard; Injection really hurt; Developed 4 inch bruise; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard) and INJECTION SITE PAIN (Injection really hurt) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard), INJECTION SITE PAIN (Injection really hurt) and VACCINATION SITE BRUISING (Developed 4 inch bruise). At the time of the report, VACCINATION SITE REACTION (COVID arm), PERIPHERAL SWELLING (Arm was swollen, could not touch shoulder), ERYTHEMA (Red arm, redness down elbow to shoulder), INDURATION (Arm was hard), INJECTION SITE PAIN (Injection really hurt) and VACCINATION SITE BRUISING (Developed 4 inch bruise) outcome was unknown. Not provided          No relevant concomitant product use was reported.  Treatment details included clindamycin.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Muscular weakness, Myalgia, Pyrexia
Clinical narrative: Soreness at injection arm/the injection arm is extremely sore; not able to sleep; not able to move or lift the arm above the head; fatigue; fever; extreme muscle cramps; arm was tender to touch; restless; felt more sleepy; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (not able to sleep), TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy) and MUSCULAR WEAKNESS (not able to move or lift the arm above the head) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Past medical history not provided). Concomitant products included PANTOPRAZOLE and VITAMINS NOS for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy), MYALGIA (extreme muscle cramps) and PYREXIA (fever). On 08-Apr-2021, the patient experienced INSOMNIA (not able to sleep), MUSCULAR WEAKNESS (not able to move or lift the arm above the head) and FATIGUE (fatigue). On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at injection arm/the injection arm is extremely sore). At the time of the report, INSOMNIA (not able to sleep), TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy), MUSCULAR WEAKNESS (not able to move or lift the arm above the head), MYALGIA (extreme muscle cramps), FATIGUE (fatigue), PYREXIA (fever) and VACCINATION SITE PAIN (Soreness at injection arm/the injection arm is extremely sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment activities for event was done with ibuprofen.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness, Somnolence, Tenderness, Vaccination site pain
Clinical narrative: Soreness at injection arm/the injection arm is extremely sore; not able to sleep; not able to move or lift the arm above the head; fatigue; fever; extreme muscle cramps; arm was tender to touch; restless; felt more sleepy; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (not able to sleep), TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy) and MUSCULAR WEAKNESS (not able to move or lift the arm above the head) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Past medical history not provided). Concomitant products included PANTOPRAZOLE and VITAMINS NOS for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy), MYALGIA (extreme muscle cramps) and PYREXIA (fever). On 08-Apr-2021, the patient experienced INSOMNIA (not able to sleep), MUSCULAR WEAKNESS (not able to move or lift the arm above the head) and FATIGUE (fatigue). On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at injection arm/the injection arm is extremely sore). At the time of the report, INSOMNIA (not able to sleep), TENDERNESS (arm was tender to touch), RESTLESSNESS (restless), SOMNOLENCE (felt more sleepy), MUSCULAR WEAKNESS (not able to move or lift the arm above the head), MYALGIA (extreme muscle cramps), FATIGUE (fatigue), PYREXIA (fever) and VACCINATION SITE PAIN (Soreness at injection arm/the injection arm is extremely sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment activities for event was done with ibuprofen.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Vaccination site pain
Clinical narrative: Severe neck pain; Severe shoulder pain; Pain under the ampit at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site). The patient was treated with PARACETAMOL at an unspecified dose and frequency. At the time of the report, NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching on the midsection of the body; Broke out on both legs/Broke out all around on the waist/Breaking out on the face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on the midsection of the body) and RASH (Broke out on both legs/Broke out all around on the waist/Breaking out on the face) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PRURITUS (Itching on the midsection of the body) and RASH (Broke out on both legs/Broke out all around on the waist/Breaking out on the face). The patient was treated with PREDNISONE for Adverse event, at a dose of 40 mg and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching on the midsection of the body) and RASH (Broke out on both legs/Broke out all around on the waist/Breaking out on the face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up received on 07 Aug 2021 and outcome was updated from unknown to Resolved.Correction made from initial version: Reporter's contact detail and Product indication was updated/corrected. All the three events Broke out on both legs, Broke out all around on the waist, Breaking out on the face, were merged into one.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.            Patient was not sure to get the vaccine due to the ingredient (Polyethylene). However, caller reported that he received both doses of the vaccine and did not have any issues other than a minor rash.   Treatment medication was not provided  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.   This case was linked to MOD-2021-072708 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy
Clinical narrative: Extremely exhausted; The glands on the right side of his throat were inflamed like a miniature golf ball.; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely exhausted) and LYMPHADENOPATHY (The glands on the right side of his throat were inflamed like a miniature golf ball.) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Extremely exhausted) and LYMPHADENOPATHY (The glands on the right side of his throat were inflamed like a miniature golf ball.). At the time of the report, FATIGUE (Extremely exhausted) and LYMPHADENOPATHY (The glands on the right side of his throat were inflamed like a miniature golf ball.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information were not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Dizziness, Headache, Hypersomnia
Clinical narrative: Dizziness; Sleep excessive; Depressed Mood; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HYPERSOMNIA (Sleep excessive), DEPRESSED MOOD (Depressed Mood) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness), HYPERSOMNIA (Sleep excessive), DEPRESSED MOOD (Depressed Mood) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), HYPERSOMNIA (Sleep excessive), DEPRESSED MOOD (Depressed Mood) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided. No concomitant medication were provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia
Clinical narrative: muscle pain; headache; dizziness; lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain), HEADACHE (headache), DIZZINESS (dizziness) and DIZZINESS (lightheaded) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SPIRONOLACTONE and ESTRADIOL for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced MYALGIA (muscle pain), HEADACHE (headache), DIZZINESS (dizziness) and DIZZINESS (lightheaded). At the time of the report, MYALGIA (muscle pain), HEADACHE (headache), DIZZINESS (dizziness) and DIZZINESS (lightheaded) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication were not reported/unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Headaches; Sore left arm/ feeling achy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm/ feeling achy), PYREXIA (Fever) and HEADACHE (Headaches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concurrent medical conditions included Hypertension, Abdominal discomfort, Drug allergy and Anxiety. Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Abdominal discomfort.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm/ feeling achy) and PYREXIA (Fever). On 09-Apr-2021, the patient experienced HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (Sore left arm/ feeling achy), PYREXIA (Fever) and HEADACHE (Headaches) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Aspirin and Multivitamins.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-072728 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072728:dose 1
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. Patient was not sure to get the vaccine due to the ingredient (Polyethylene). However, caller reported that he received both doses of the vaccine and did not have any issues other than a minor rash. No information on concomitant medicine. No information on treatment. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable. This case was linked to MOD-2021-072701. Reporter did not allow further contact.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Pain in extremity, Swelling face
Clinical narrative: Cold feeling in left calf; Pain in vein of left calf; Swelling on right side of face, especially eye.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold feeling in left calf), PAIN IN EXTREMITY (Pain in vein of left calf) and SWELLING FACE (Swelling on right side of face, especially eye.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced SWELLING FACE (Swelling on right side of face, especially eye.). On 09-Apr-2021, the patient experienced FEELING COLD (Cold feeling in left calf) and PAIN IN EXTREMITY (Pain in vein of left calf). At the time of the report, FEELING COLD (Cold feeling in left calf), PAIN IN EXTREMITY (Pain in vein of left calf) and SWELLING FACE (Swelling on right side of face, especially eye.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: underage vaccination; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage vaccination) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage vaccination). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage vaccination) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information were reported.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea
Clinical narrative: Chest pain; Coughing; Trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), COUGH (Coughing) and DYSPNOEA (Trouble breathing) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced CHEST PAIN (Chest pain). 09-Apr-2021, the patient experienced COUGH (Coughing) and DYSPNOEA (Trouble breathing). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown and COUGH (Coughing) and DYSPNOEA (Trouble breathing) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 001B21A) for an unknown indication.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.         No concomitant medications were reported.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: headache; fever reached (100.1 F); fever (99.4 F); feeling achy; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE, PAIN, PAIN IN EXTREMITY, PYREXIA, and PYREXIA in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 010A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension. Concomitant products included PROTONIX and ASPIRIN for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY. On 08-Apr-2021, the patient experienced PAIN and PYREXIA. On 09-Apr-2021, the patient experienced HEADACHE and PYREXIA. At the time of the report, HEADACHE, PAIN, PAIN IN EXTREMITY, PYREXIA, and PYREXIA outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 99.4 F. On 09-Apr-2021, Body temperature: 100.1 F.         concomitant medication include Unknown hypertension medication, Protonix, aspirin, multivitamins, Unknown anxiety medication. Treatment information was not provided Action taken with mRNA in response to the events was not applicable.  .   This case was linked to US-MODERNATX, INC-MOD-2021-072707. Sender's Comments:  US-MODERNATX, INC-MOD-2021-072707.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: dose of the Moderna vaccine to a 17 year old; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose of the Moderna vaccine to a 17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 034C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose of the Moderna vaccine to a 17 year old). On 07-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose of the Moderna vaccine to a 17 year old) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were  reported   No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Updated the patient demographics. On 26-May-2021: Follow-up received. Patient' s gender changed. Second dose details were added.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Insomnia, Malaise
Clinical narrative: "I did not feel well for 2 days"; Chills; "I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a; could not sleep; urinated all night about every hour in the night; elevated temperature; loss of energy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night) and PYREXIA (elevated temperature) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event. Concomitant products included DULOXETINE, FISH OIL, ROSUVASTATIN, VITAMIN D3 and MULTIVITAMIN & MINERAL.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy). On an unknown date, the patient experienced MALAISE ("I did not feel well for 2 days"). On 07-Apr-2021, CHILLS (Chills), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy) outcome was unknown. At the time of the report, HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a) and MALAISE ("I did not feel well for 2 days") outcome was unknown. Not Provided          Treatment information were not provided.    Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pollakiuria, Pyrexia
Clinical narrative: "I did not feel well for 2 days"; Chills; "I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a; could not sleep; urinated all night about every hour in the night; elevated temperature; loss of energy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night) and PYREXIA (elevated temperature) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event. Concomitant products included DULOXETINE, FISH OIL, ROSUVASTATIN, VITAMIN D3 and MULTIVITAMIN & MINERAL.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy). On an unknown date, the patient experienced MALAISE ("I did not feel well for 2 days"). On 07-Apr-2021, CHILLS (Chills), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy) outcome was unknown. At the time of the report, HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a) and MALAISE ("I did not feel well for 2 days") outcome was unknown. Not Provided          Treatment information were not provided.    Reporter did not allow further contact
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: Swollen like a knot; Red rash under it; Red rash under it; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen like a knot), VACCINATION SITE RASH (Red rash under it) and VACCINATION SITE ERYTHEMA (Red rash under it) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AZITHROMYCIN for an unknown indication.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swollen like a knot), VACCINATION SITE RASH (Red rash under it) and VACCINATION SITE ERYTHEMA (Red rash under it). At the time of the report, VACCINATION SITE SWELLING (Swollen like a knot), VACCINATION SITE RASH (Red rash under it) and VACCINATION SITE ERYTHEMA (Red rash under it) outcome was unknown.            Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: No significant information was received.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Doses of the Moderna vaccine were administered after 12 hours since the vials was first used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses of the Moderna vaccine were administered after 12 hours since the vials was first used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses of the Moderna vaccine were administered after 12 hours since the vials was first used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses of the Moderna vaccine were administered after 12 hours since the vials was first used) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 05-Aug-2021 and included non-significant information
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site bruising, Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site got bruised; Injection site got red; Injection site tender to the touch; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Injection site got bruised), PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE ERYTHEMA (Injection site got red) and VACCINATION SITE PAIN (Injection site tender to the touch) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Injection site got bruised), VACCINATION SITE ERYTHEMA (Injection site got red) and VACCINATION SITE PAIN (Injection site tender to the touch). On 30-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, VACCINATION SITE BRUISING (Injection site got bruised), VACCINATION SITE ERYTHEMA (Injection site got red) and VACCINATION SITE PAIN (Injection site tender to the touch) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included Anti-histamines and Antacid.  Treatment information was not provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Feeling abnormal, Gait disturbance
Clinical narrative: can barely walk; Feels like its on fire; Back was bothering him; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back was bothering him), GAIT DISTURBANCE (can barely walk) and FEELING ABNORMAL (Feels like its on fire) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced BACK PAIN (Back was bothering him). On 09-Apr-2021, the patient experienced GAIT DISTURBANCE (can barely walk) and FEELING ABNORMAL (Feels like its on fire). At the time of the report, BACK PAIN (Back was bothering him) outcome was unknown and GAIT DISTURBANCE (can barely walk) and FEELING ABNORMAL (Feels like its on fire) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026B21A) for COVID-19 immunization. No reported medical history. On Apr 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 1, 2021, patient experienced vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection). The patient treated with ibuprofen, at an unspecified dose and frequency. At the time of the report, vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use not provided.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Pain in extremity, Pruritus
Clinical narrative: Pain in the arm; Itchiness; Very dizzy; Nauseated; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), PRURITUS (Itchiness), DIZZINESS (Very dizzy), NAUSEA (Nauseated) and HEADACHE (Headache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No relevant medical history was provided by the reporter.  Concomitant products included ROSUVASTATIN and METFORMIN HYDROCHLORIDE (GLUMETZA) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the arm), PRURITUS (Itchiness), DIZZINESS (Very dizzy), NAUSEA (Nauseated) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) and PRURITUS (Itchiness) had resolved and DIZZINESS (Very dizzy), NAUSEA (Nauseated) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No medical history. ).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme increased
Clinical narrative: Liver enzymes elevated; This spontaneous case was reported by a patient and describes the occurrence of HEPATIC ENZYME INCREASED (Liver enzymes elevated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 007B21A) for an unknown indication.     The patient's past medical history included No adverse event (Medical history was not provided.). Concomitant products included AMLODIPINE, METFORMIN, GABAPENTIN, HYDROCHLOROTHIAZIDE, VALSARTAN (VALSARTAN & HCTZ), POTASSIUM, LEVOTHYROXINE, ATORVASTATIN CALCIUM (LIPITOR), FUROSEMIDE (LASIX [FUROSEMIDE]), ASPIRIN [ACETYLSALICYLIC ACID] and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (Liver enzymes elevated). At the time of the report, HEPATIC ENZYME INCREASED (Liver enzymes elevated) outcome was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Rash
Clinical narrative: With my first shot I was just extremely tired and exhausted. With my second shot I was tired the next morning. I had a rash momentarily on my face. As the day progressed I had cramping and tummy pain. I had excessive diarrhea starting at 4 until about 11 on and off. Headache as well. Today woke up and felt better. Got to work. Had a small case of diarrhea again. Went home. Rested. Had another 2 bouts of diarrhea. Headache has lingered on and off.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea vomiting
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Doesn't feel like eating; Aches and pain in her leg; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Doesn't feel like eating), PAIN IN EXTREMITY (Aches and pain in her leg), PYREXIA (Fever) and VOMITING (Vomiting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced DECREASED APPETITE (Doesn't feel like eating), PAIN IN EXTREMITY (Aches and pain in her leg), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, DECREASED APPETITE (Doesn't feel like eating), PAIN IN EXTREMITY (Aches and pain in her leg), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.            No concomitant medications were reported. No treatment related information has been reported.  Based in current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD21-053012 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: No specific follow-up information recorded.; Sender's Comments: Based in current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. MOD21-053012:Cross link
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall, Fatigue, Headache, Immediate post-injection reaction
Clinical narrative: The patient mentioned having slight light-headedness immediately after the vaccination was given, which was followed by temporary loss of consciousness about 2 minutes after administration.  He regained consciousness within a minute.  He had fallen to the floor, where we laid him out with his head slightly elevated on a bag of rice.  His pulse was detected during the initial response following syncope.  His face had a pale complexion and his body had tensed up before he became responsive again.  We allowed the patient to continue to lie down until he felt better.  We slowly sat him up on the floor and slowly helped him to a nearby chair, which was about 15 minutes following syncope.  Within a couple of minutes, patient stated feeling light-headed again, so we slowly moved him back down to the floor to lie down again.  He rested there for approximately 20 minutes, then we helped him to the chair to sit again.  The patient was offered water and a snack bar.  He sipped on the water a couple of times while seated in the chair.  The patient was stable enough to leave the pharmacy about an hour after vaccination administration.  EMS was called when the incident occurred, but the patient refused to have them come to the pharmacy to check on him.  The day after the incident, the patient stated having a headache and feeling a little tired.  But, overall, he is doing fine.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Pallor, Syncope, Tension
Clinical narrative: The patient mentioned having slight light-headedness immediately after the vaccination was given, which was followed by temporary loss of consciousness about 2 minutes after administration.  He regained consciousness within a minute.  He had fallen to the floor, where we laid him out with his head slightly elevated on a bag of rice.  His pulse was detected during the initial response following syncope.  His face had a pale complexion and his body had tensed up before he became responsive again.  We allowed the patient to continue to lie down until he felt better.  We slowly sat him up on the floor and slowly helped him to a nearby chair, which was about 15 minutes following syncope.  Within a couple of minutes, patient stated feeling light-headed again, so we slowly moved him back down to the floor to lie down again.  He rested there for approximately 20 minutes, then we helped him to the chair to sit again.  The patient was offered water and a snack bar.  He sipped on the water a couple of times while seated in the chair.  The patient was stable enough to leave the pharmacy about an hour after vaccination administration.  EMS was called when the incident occurred, but the patient refused to have them come to the pharmacy to check on him.  The day after the incident, the patient stated having a headache and feeling a little tired.  But, overall, he is doing fine.
Age: 30.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid pos after vaccination
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Admitted for breakthrough COVID infection. Treating with Dexamethsone and Redemsivir